Liu Yu, Zhao Wanyu, Lu Ying, Zhao Yunli, Zhang Yan, Dai Miao, Hai Shan, Ge Ning, Zhang Shuting, Huang Mingjin, Liu Xiaohui, Li Shuangqing, Yue Jirong, Lei Peng, Dong Biao, Dai Lunzhi, Dong Birong
National Clinical Research Center for Geriatrics and Department of General Practice State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu China.
Department of Health Research Methods, Evidence, and Impact McMaster University Hamilton Ontario Canada.
MedComm (2020). 2022 Sep 30;3(4):e165. doi: 10.1002/mco2.165. eCollection 2022 Dec.
Mental disorders are associated with dysregulated metabolism, but comprehensive investigations of their metabolic similarities and differences and their clinical relevance are few. Here, based on the plasma metabolome and lipidome of subcohort1, comprising 100 healthy participants, 55 cases with anxiety, 52 persons with depression, and 41 individuals with comorbidity, which are from WCHAT, a perspective cohort study of community-dwelling older adults aged over 50, multiple metabolites as potential risk factors of mental disorders were identified. Furthermore, participants with mental illnesses were classified into three subtypes (S1, S2, and S3) by unsupervised classification with lipidomic data. Among them, S1 showed higher triacylglycerol and lower sphingomyelin, while S2 displayed opposite features. The metabolic profile of S3 was like that of the normal group. Compared with S3, individuals in S1 and S2 had worse quality of life, and suffered more from sleep and cognitive disorders. Notably, an assessment of 6,467 individuals from the WCHAT showed an age-related increase in the incidence of depression. Seventeen depression-related metabolites were significantly correlated with age, which were validated in an independent subcohort2. Collectively, this work highlights the clinical relevance of metabolic perturbation in mental disorders, and age-related metabolic disturbances may be a bridge-linking aging and depressive.
精神障碍与代谢失调有关,但对其代谢异同及其临床相关性的全面研究却很少。在此,基于来自WCHAT(一项针对50岁以上社区居住老年人的前瞻性队列研究)的亚队列1的血浆代谢组和脂质组,该亚队列包括100名健康参与者、55例焦虑症患者、52例抑郁症患者和41例合并症患者,确定了多种代谢物作为精神障碍的潜在危险因素。此外,利用脂质组学数据通过无监督分类将患有精神疾病的参与者分为三个亚型(S1、S2和S3)。其中,S1显示出较高的甘油三酯和较低的鞘磷脂,而S2则表现出相反的特征。S3的代谢谱与正常组相似。与S3相比,S1和S2的个体生活质量较差,睡眠和认知障碍更严重。值得注意的是,对来自WCHAT的6467名个体的评估显示,抑郁症发病率随年龄增长而增加。17种与抑郁症相关的代谢物与年龄显著相关,这在独立的亚队列2中得到了验证。总体而言,这项工作突出了精神障碍中代谢紊乱的临床相关性,与年龄相关的代谢紊乱可能是连接衰老和抑郁的桥梁。